Showing 9211-9220 of 20379 results for "".
- Older Adults with Diabetes Faced Elevated Risk of Depression During the COVID-19 Pandemichttps://reachmd.com/news/older-adults-with-diabetes-faced-elevated-risk-of-depression-during-the-covid-19-pandemic/2467643/A recent study of more than 2,700 older Canadians reported older adults with diabetes faced a heightened risk of depression during the COVID-19 pandemic. In this cohort, almost 50% of those who had a pre-pandemic history of depression experienced
- UACR And UPCR In CKD Trials: Kidney Failure Riskhttps://reachmd.com/news/uacr-upcr-ckd-trials-kidney-failure-risk/2486897/Key Takeaways UACR AND UPCR were strongly associated with kidney failure, with UACR showing the stronger pooled association. The difference was clearest in type 2 diabetes and CKD and less clear in glomerular disease. In a
- GLP-1 Receptor Agonists: Bridging Metabolic Control and Cardiovascular Protectionhttps://reachmd.com/news/glp-1-receptor-agonists-bridging-metabolic-control-and-cardiovascular-protection/2475771/The expanding use of GLP-1 receptor agonists such as Ozempic is challenging the traditional divide between metabolic control and cardiovascular protection, unveiling underrecognized potential for stroke prevention in patients with type 2 diabetes. The utilization of
- Weight Loss and Glucose Management: Transitioning from Old to New Medicationshttps://reachmd.com/news/weight-loss-and-glucose-management-transitioning-from-old-to-new-medications/2474175/Emerging research affirms that next-generation weight loss and glucose management medications are transforming treatment outcomes for patients with type 2 diabetes, offering superior efficacy and potential economic savings. The advent of these c
- Therapeutic Plasma Exchange and Biological Aging: A New Hope in Geriatricshttps://reachmd.com/news/therapeutic-plasma-exchange-and-biological-aging-a-new-hope-in-geriatrics/2474990/Clinicians have long sought interventions capable of reversing biological aging and improving patient resilience, and now a
- Compound from Olives Shows Promise for Treating Obesity and Diabetes, Claims Studyhttps://reachmd.com/news/compound-from-olives-shows-promise-for-treating-obesity-and-diabetes-claims-study/2467587/Chicago: Findings from a new mouse study suggest that elenolic acid, a natural compound found in olives, can lower blood sugar levels and promote weight loss.The research could pave the way to the development of safe and inexpensive natural products for managing
- Study Reveals Avocado May Lower Diabetes Risk in Women, Not Menhttps://reachmd.com/news/study-reveals-avocado-may-lower-diabetes-risk-in-women-not-men/2463092/In a recent cross-sectional study published in the Journal of the Academy of Nutrition and Dietetics, researchers from Mexico investigat
- New Study Focuses on the Placenta for Clues to the Development of Gestational Diabeteshttps://reachmd.com/news/new-study-focuses-on-the-placenta-for-clues-to-the-development-of-gestational-diabetes/2462758/Marie-France Hivert, MD, MMSc BOSTON, MA – A new study led by the Harvard Pilgrim Health Care Institute has identified that a deficit in the placental expression of the gene insulin-like growth factor 1 (IGFBP1) and low IGFBP
- Machine Learning Can Predict Eyes at Risk for Diabetic Retinopathy Progressionhttps://reachmd.com/news/machine-learning-can-predict-eyes-at-risk-for-diabetic-retinopathy-progression/2457233/by Lori Solomon Automated machine learning models may help identify eyes
- Barriers To SGLT2 Inhibitor Access In Heart Failure Care In Jordanhttps://reachmd.com/news/barriers-to-sglt2-inhibitor-access-in-heart-failure-care-in-jordan/2486587/Key Takeaways: Low initiation and low reported approval for heart failure without diabetes were observed despite generally favorable physician knowledge and attitudes toward SGLT2 inhibitors. Misclassification of SGLT2 inhibitors as diabetes-only medic